Skip to main content
Mina Lobbous, MD, Neurology, Cleveland, OH, Cleveland Clinic

MinaLobbousMD

Neurology Cleveland, OH

Neurooncology

Assistant Professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Dr. Lobbous is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lobbous' full profile

Already have an account?

  • Office

    Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center
    9500 Euclid Avenue/CA51
    Cleveland, OH 44195
    Phone+1 216-445-1379
    Fax+1 216-444-0924
  • Is this information wrong?

Education & Training

  • University of Alabama at Birmingham School of Public Health
    University of Alabama at Birmingham School of Public HealthMSPH, Epidemiology , 2018 - 2021
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Neurology, 2014 - 2018
  • Ain Shams University Faculty of Medicine
    Ain Shams University Faculty of MedicineClass of 2012

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2021 - 2025
  • AL State Medical License
    AL State Medical License 2016 - 2022
  • American Board of Psychiatry and Neurology Neurology
  • United Council for Neurology SubspecialtiesNeuro-Oncology

Publications & Presentations

PubMed

Journal Articles

  • An evaluation of selumetinib for the treatment of neurofibromatosis type 1-associated symptomatic, inoperable plexiform neurofibromas  
    Katie Metrock, Mina Lobbous, Bruce Korf, Expert Review of Precision Medicine and Drug Development, 7/2021

Books/Book Chapters

Abstracts/Posters

  • Phase 1 trial of drug resistant immunotherapy: A first-in-class combination of MGMT-modified γδ t cells and temozolomide chemotherapy in newly diagnosed glioblastoma
    Louis B. Nabors, Lawrence S. Lamb, Melissa Jo Beelen, Thriumaine Pillay, Mariska ter Haak, Samantha Youngblood, Louis Vaickus, Mina Lobbous, ASCO 2021
  • Pharmacokinetic (PK) analyses in CSF and plasma from TBCRC049, an ongoing trial to assess the safety and efficacy of the combination of tucatinib, trastuzumab and cape...
    Erica Michelle Stringer-Reasor, Barbara Jane O'Brien, Ariel Topletz-Erickson, Jason B White, Mina Lobbous, Kristen Riley, Jennifer Childress, Kim LaMaster, Michelle E...., ASCO 2021
  • Phase 2 trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001
    Katherine B. Peters, John L. Villano, Nicholas A. Butowski, Adam Louis Cohen, Joe Sammy Mendez, Pierre Giglio, Chi Zhang, Shahzad Raza, Tresa McGranahan, Mina Lobbous,..., ASCO 2021

Other

Press Mentions

  • IN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual Meeting
    IN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual MeetingNovember 11th, 2023

Professional Memberships

Hospital Affiliations